Selective modulation of B-cell activation markers CD86 and I-Ak on murine draining lymph node cells following allergen or irritant treatment

被引:25
|
作者
Gerberick, GF [1 ]
Cruse, LW [1 ]
Miller, CM [1 ]
Ridder, GM [1 ]
机构
[1] Procter & Gamble Co, Miami Valley Labs, Cincinnati, OH 45253 USA
关键词
allergens; irritants; local lymph node assay; B cells; T cells; costimulatory molecules; MHC class II; flow cytometry;
D O I
10.1006/taap.1999.8734
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
It is well known that T cells are key effector cells in the development of allergic contact dermatitis. However, we and others have shown that mice exposed to contact allergens show a preferential increase in B lymphocytes in the draining lymph nodes (DLN) as seen by an increase in the percentage of B220(+) or IgG/IgM(+) cells. The purpose of the present investigation was to determine whether chemical allergens, in contrast to irritants, would modulate B-cell activation markers, CD86 and I-A(k), on B cells isolated from DLN of treated mice using the local lymph node assay (LLNA) protocol. Mice were treated on the ears for 3 consecutive days with concentrations of allergens (1-chloro-2,4-dinitrobenzene, alpha-hexylcinnamaldehyde, 4-ethoxymethylene-2-phenyl-2-oxazoline-5-one, and trinitrochlorobenzene), or irritants (benzalkonium chloride and sodium lauryl sulfate), which caused an increase in the number of DLN cells. The DLN were excised 72 h following the final chemical treatment, and the cells were prepared for analysis by dow cytometry. In mice treated with allergens an increase in the median intensity of I-A(kappa) and CD86 on B220(+) or IgG/IgM(+) B cells was observed compared to mice treated with irritants or vehicles. Mice treated with allergens demonstrated an increase in the median intensity of CD86 on B220(+) B cells that was dose dependent and peaked at 72 h following the find allergen treatment. The increase in the median intensity of I-A(kappa) also was dose dependent but peaked at 96 h. Finally, T and B cells isolated from both allergen- and irritant-treated mice demonstrated an increase in [H-3]thymidine incorporation compared to vehicle-treated and naive mice at 72 h following the final chemical treatment. The results suggest that B cells isolated from DLN of allergen-treated mice are activated and proliferating. Analysis of B-cell activation markers may be useful in differentiating allergen and irritant responses in the draining lymph nodes of chemically treated mice. (C) 1999 Academic Press.
引用
收藏
页码:142 / 151
页数:10
相关论文
共 8 条
  • [1] Selective modulation of T cell activation markers CD62L and CD44 on murine draining lymph node cells following allergen or irritant treatment.
    Gerberick, GF
    Cruse, LW
    Miller, CM
    Sikorski, EE
    Ridder, GM
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1997, 108 (04) : 585 - 585
  • [2] Selective modulation of T cell memory markers CD62L and CD44 on murine draining lymph node cells following allergen and irritant treatment
    Gerberick, GF
    Cruse, LW
    Miller, CM
    Sikorski, EE
    Ridder, GM
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 1997, 146 (01) : 1 - 10
  • [3] Modulation of intracellular cytokines in draining lymph node cells following allergen and irritant
    Lee, JK
    Park, JH
    Eom, JH
    Kim, HS
    Oh, HY
    ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY, 2005, 20 (01) : 225 - 232
  • [4] Differential expression of CD86, CD40, and Iak on B cells isolated from draining lymph nodes (DLN) of allergen or irritant treated mice.
    Gerberick, GF
    Cruse, LW
    Miller, CM
    Ridder, GM
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1998, 110 (04) : 644 - 644
  • [5] The effect of time and dose on the phenotypic expression of activation makers (Cd86 and IAS an B cells isolated from the DLN of allergen and irritant treated mice
    Gerberick, G
    Cruse, L
    Miller, C
    Ridder, G
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1999, 112 (04) : 597 - 597
  • [6] TREATMENT OF MURINE CD5- B-CELLS WITH ANTI-IG, BUT NOT LPS, INDUCES SURFACE CD5 - 2 B-CELL ACTIVATION PATHWAYS
    CONG, YZ
    RABIN, E
    WORTIS, HH
    INTERNATIONAL IMMUNOLOGY, 1991, 3 (05) : 467 - 476
  • [7] TREATMENT OF MURINE CD5 B-CELLS WITH ANTI-IG, BUT NOT LPS, INDUCES SURFACE CD5 - 2 B-CELL ACTIVATION PATHWAYS
    WORTIS, HH
    CONG, YZ
    RABIN, E
    FASEB JOURNAL, 1991, 5 (05): : A968 - A968
  • [8] PD-L1-expressing B cells promote murine breast cancer development and mediate the response to anti-PD-L1 immune checkpoint inhibitor to upregulate B-cell CD86 and inhibit tumor growth.
    Khan, Mustafa T.
    Cervantes, Christian
    Liu, Zexuan
    Viswanadhapalli, Suryavathi
    Gupta, Harshita
    Curiel, Tyler
    Vadlamudi, Ratna
    Xu, Zhenming
    CANCER RESEARCH, 2021, 81 (13)